Clinical Therapeutics

Editorial Comment
pp. 898-898(1)
Author: Walson P.D.

Diabetes Guidelines: A Summary and Comparison of the Recommendations of the American Diabetes Association, Veterans Health Administration, and American Association of Clinical Endocrinologists
pp. 899-910(12)
Authors: Clark M.J.; Sterrett J.J.; Carson D.S.

Clinical Manifestations and Management of Antiretroviral Nucleoside Analog-Related Mitochondrial Toxicity
pp. 911-936(26)
Author: Moyle G.

Use of Direct Thrombin Inhibitors in Acute Coronary Syndrome
pp. 937-948(12)
Authors: Nemergut C.; Cheng J.W.M.

Benefits of Early Lipid-Lowering Intervention in High-Risk Patients: The Lipid Intervention Strategies for Coronary Patients Study
pp. 949-960(12)
Authors: Pedersen T.R.; Jahnsen K.E.; Vatn S.; Semb A.G.; Kontny F.; Zalmai A.; Nerdrum T.

Efficacy of Valsartan in Patients Aged =<65 Years with Systolic Hypertension
pp. 961-969(9)
Authors: Neutel J.M.; Bedigian M.P.

Efficacy of Naratriptan Tablets in the Acute Treatment of Migraine: A Dose-Ranging Study
pp. 970-980(11)
Authors: Havanka H.; Dahlof C.; Pop P.H.M.; Diener H.-C.; Winter P.; Whitehouse H.; Hassani H.

Comparison of Naratriptan and Sumatriptan in Recurrence-Prone Migraine Patients
pp. 981-989(9)
Authors: Gobel H.; Winter P.; Boswell D.; Crisp A.; Becker W.; Hauge T.; Mihout B.; Niewold J.; Torring J.

Dose-Response Effect of Combination Hydrocodone with Ibuprofen in Patients with Moderate to Severe Postoperative Pain
pp. 990-1002(13)
Authors: Palangio M.; Wideman G.L.; Keffer M.; Landau C.J.; Morris E.; Doyle R.T.; Jiang J.G.; Damask M.; de Padova A.